How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
VSD Occluder Device Market
- By Product Type: Self-Expanding VSD Occluder, Balloon-Expandable VSD Occluder, Biodegradable VSD Occluder, Nitinal VSD Occluder
- By Material Type: Nitinol, Polyester Fabric, Polytetrafluoroethylene (PTFE), Biodegradable Polymers
- By Ventricular Septal Defect Type: Perimembranous VSD, Muscular VSD, Inlet VSD, Outlet (Supracristal) VSD
- By End User: Hospitals, Cardiac Specialty Clinics, Ambulatory Surgical Centers
- By Procedure Type: Transcatheter VSD Closure, Surgical VSD Closure
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Self-Expanding VSD Occluder leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the VSD Occluder Device Market report
A complete, evidence-based study - 12 chapters and 116 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Material Type 4
Ventricular Septal Defect Type 4
End User 3
Procedure Type 2
Companies profiled
Abbott Laboratories
Lifetech Scientific
Occlutech International AB
Shanghai Shape Memory Alloy Co. Ltd.
CardioTech International Ltd.
Lepu Medical Technology (Beijing) Co. Ltd.
Vascular Innovations Co. Ltd.
LivaNova PLC
Medtronic plc
MicroPort Scientific Corporation
Sino Medical Sciences Technology Inc.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Lifetech Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Occlutech International AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shanghai Shape Memory Alloy Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →CardioTech International Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Lepu Medical Technology (Beijing) Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Vascular Innovations Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →LivaNova PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Medtronic plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →MicroPort Scientific Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Sino Medical Sciences Technology Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$839.7M by 2033 · 6.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Self-Expanding VSD Occluder53.4
- Balloon-Expandable VSD Occluder12.0
- Biodegradable VSD Occluder16.9
- Nitinal VSD Occluder17.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$164.8M → $284.8M · 7.1%
Europe$114.9M → $184.9M · 6.1%
Asia Pacific$104.9M → $157.2M · 5.2%
Latin America$64.9M → $112.8M · 7.1%
Middle East and Africa$49.9M → $78.8M · 5.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.672026
6.672027
6.682028
6.712029
6.702030
6.732031
6.742032
6.742033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories17.3
- Lifetech Scientific9.6
- Occlutech International AB9.9
- Shanghai Shape Memory Alloy Co. Ltd.13.5
- CardioTech International Ltd.11.9
- Lepu Medical Technology (Beijing) Co. Ltd.9.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type23.6%
Material Type22.3%
Ventricular Septal Defect Type12.7%
End User23.8%
Procedure Type17.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.8
- Europe22.6
- Asia Pacific19.2
- Latin America13.8
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 85 | 77 | 93 | 84 | 95 | 82 | 86 |
| Lifetech Scientific | 82 | 77 | 87 | 73 | 72 | 83 | 79 |
| Occlutech International AB | 84 | 74 | 65 | 76 | 87 | 83 | 78 |
| Shanghai Shape Memory Alloy Co. Ltd. | 66 | 58 | 70 | 60 | 72 | 60 | 64 |
| CardioTech International Ltd. | 65 | 59 | 76 | 58 | 74 | 64 | 66 |
| Lepu Medical Technology (Beijing) Co. Ltd. | 66 | 50 | 65 | 57 | 46 | 63 | 58 |
| Vascular Innovations Co. Ltd. | 48 | 65 | 43 | 56 | 49 | 60 | 54 |
| LivaNova PLC | 50 | 36 | 53 | 38 | 60 | 41 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- Lifetech Scientific
- Occlutech International AB
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Lifetech Scientific | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Occlutech International AB | ✓ | ◐ | − | ✓ | ◐ | ✓ |
| Shanghai Shape Memory Alloy Co. Ltd. | − | ◐ | ◐ | − | ✓ | − |
| CardioTech International Ltd. | ◐ | − | ◐ | ◐ | ◐ | ✓ |
| Lepu Medical Technology (Beijing) Co. Ltd. | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Vascular Innovations Co. Ltd. | ◐ | ◐ | − | ◐ | − | ◐ |
| LivaNova PLC | − | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Abbott Laboratories86
2Lifetech Scientific79
3Occlutech International AB78
4CardioTech International Ltd.66
5Shanghai Shape Memory Alloy Co. Ltd.64
6Lepu Medical Technology (Beijing) Co. Ltd.58
7Vascular Innovations Co. Ltd.54
8LivaNova PLC46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Abbott LaboratoriesLifetech ScientificOcclutech International AB
Contender3
Focused players with pockets of strength.
Shanghai Shape Memory Alloy Co. Ltd.CardioTech International Ltd.Lepu Medical Technology (Beijing) Co. Ltd.
Niche2
Specialists in a single segment or region.
Vascular Innovations Co. Ltd.LivaNova PLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across VSD Occluder Device Market — a $546M beachhead inside a $8.80B market.
Beachhead (SOM)$546Mobtainable near-term
Serviceable (SAM)$3.25Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Self-Expanding VSD Occluder
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Balloon-Expandable VSD Occluder
Strong fit — clear ROI and a fast path to value.
End user70 fit
Biodegradable VSD Occluder
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Ventricular Septal Defect Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win VSD Occluder Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified25%
Evaluation13%
Closed-won6%
$17.3KCAC
$79KLTV
4.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
VSD Occluder Device Market is a high-growth opportunity — $5.41B by 2033, compounding at 10.2%.
TAM · 2025$2.50Btoday
TAM · 2033$5.41Bforecast
CAGR10.2%2027–2033
Cumulative$34.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.41BTotal addressable market
SAM$2.26BServiceable available market
SOM$404MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.41BLarge & growingTAM by 2033 at 10.2% CAGR
$2.26BServiceable nowreachable with today’s model
$404MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.22BBear6.6% CAGR
$5.41BBase10.2% CAGR
$6.93BBull13.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
VSD Occluder Device Market — a $10.7B market by 2033. Plan: grow share from 8.6% to 15.2%.
Market size · 2033$10.7Btotal addressable
Market CAGR10.3%2027–2033
Target share15.2%from 8.6% today
Revenue ambition$1.63Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.6% | 15.2% | At risk |
| Revenue | $831M | $1.63B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 34.7% | 39.0% | At risk |
| Customer retention | 86.4% | 93.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material Type capability
A defensible second engine — invest in Material Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $227M capacity & capability investment
- Greenlight bolt-on M&A in Material Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the VSD Occluder Device Market conversation — a $963M market you can size, segment and defend in minutes.
Market size · 2033$963Mtotal opportunity
Growth11.4%CAGR to 2033
Addressable buyers1,601+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 4 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
Abbott LaboratoriesLifetech ScientificOcclutech International ABShanghai Shape Memory Alloy Co. Ltd.CardioTech International Ltd.Lepu Medical Technology (Beijing) Co. Ltd.Vascular Innovations Co. Ltd.LivaNova PLC+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your VSD Occluder Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
VSD Occluder Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →VSD Closure Devices Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportVR Therapy Software Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportVR Technology Medical Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportVR Surgical Training System Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportVR Ophthalmic Surgery Simulator Market
Market size, share, segmentation and regional forecast.
$910M market · 2025 base year
View reportVR Medical Solutions Market
Market size, share, segmentation and regional forecast.
$789M market · 2025 base year
View reportVR Heart Surgery Simulator Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportVR Healthcare Equipment and Service Market
Market size, share, segmentation and regional forecast.
$948M market · 2025 base year
View reportVR Headset Strabismus and Amblyopia Digital Therapeutic Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportVR for Medical Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVR-based Telerehabilitation Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVPM1002 (Tuberculosis BCG Based Vaccine) Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.